Dr. Lecia Sequist provides her thoughts on how molecular oncology can soon begin affecting treatment plans for a broader range of patients with lung cancer, including those with squamous NSCLC and other lung cancer histologies.
Podcast: Play in new windowDownload
You must be logged in to post a comment.
Subscribe toGRACE Notes (Free Newsletter)
Mission | Disclaimer